Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuo Terayama

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
Neuroscience Letters|December 1, 2009
Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2'-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative processChiaki Isobe, Takashi Abe, Yasuo Terayama
Neuro-Degenerative Diseases|November 27, 2009
Homocysteine may contribute to pathogenesis of RNA damage in brains with Alzheimer's diseaseChiaki Isobe, Takashi Abe, Yasuo Terayama
Journal of Neurology|September 29, 2009
Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2'-deoxyguanosine in the CSF of patients with Alzheimer's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative processChiaki Isobe, Takashi Abe, Yasuo Terayama
Journal of the Neurological Sciences|October 27, 2007
Increased mitochondrial oxidative damage in patients with sporadic amyotrophic lateral sclerosisTakahiko Murata, Chigumi Ohtsuka, Yasuo Terayama
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 20, 2018
Conceptual definition in the metamorphosing Parkinson's diseaseTetsuya Maeda, Kazuhiro Iwaoka, Yasuo Terayama
Neuro-Signals|April 22, 2010
Decrease in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in cerebrospinal fluid during elderly aging and in patients with sporadic form of amyotrophic lateral sclerosisChiaki Isobe, Takashi Abe, Yasuo Terayama
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 2, 2010
L-Dopa therapy increases homocysteine concentration in cerebrospinal fluid from patients with Parkinson's diseaseChiaki Isobe, Takashi Abe, Yasuo Terayama
Brain Research|October 10, 2009
Remarkable increase in 3-nitrotyrosine in the cerebrospinal fluid in patients with lacunar strokeChiaki Isobe, Takashi Abe, Yasuo Terayama
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|May 2, 2006
Increase of oxidized/total coenzyme Q-10 ratio in cerebrospinal fluid in patients with Parkinson's diseaseChiaki Isobe, Takahiko Murata, Chigumi Sato, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|May 15, 2018
Evaluation of Intraplaque Neovascularization Using Superb Microvascular Imaging and Contrast-Enhanced UltrasonographyKazumasa Oura, Tadayoshi Kato, Hideki Ohba, et al.
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Neuroscience Letters|December 1, 2009
Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2'-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative processChiaki Isobe, Takashi Abe, Yasuo Terayama
Neuro-Degenerative Diseases|November 27, 2009
Homocysteine may contribute to pathogenesis of RNA damage in brains with Alzheimer's diseaseChiaki Isobe, Takashi Abe, Yasuo Terayama
Journal of Neurology|September 29, 2009
Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2'-deoxyguanosine in the CSF of patients with Alzheimer's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative processChiaki Isobe, Takashi Abe, Yasuo Terayama
Journal of the Neurological Sciences|October 27, 2007
Increased mitochondrial oxidative damage in patients with sporadic amyotrophic lateral sclerosisTakahiko Murata, Chigumi Ohtsuka, Yasuo Terayama
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 20, 2018
Conceptual definition in the metamorphosing Parkinson's diseaseTetsuya Maeda, Kazuhiro Iwaoka, Yasuo Terayama
Neuro-Signals|April 22, 2010
Decrease in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in cerebrospinal fluid during elderly aging and in patients with sporadic form of amyotrophic lateral sclerosisChiaki Isobe, Takashi Abe, Yasuo Terayama
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 2, 2010
L-Dopa therapy increases homocysteine concentration in cerebrospinal fluid from patients with Parkinson's diseaseChiaki Isobe, Takashi Abe, Yasuo Terayama
Brain Research|October 10, 2009
Remarkable increase in 3-nitrotyrosine in the cerebrospinal fluid in patients with lacunar strokeChiaki Isobe, Takashi Abe, Yasuo Terayama
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|May 2, 2006
Increase of oxidized/total coenzyme Q-10 ratio in cerebrospinal fluid in patients with Parkinson's diseaseChiaki Isobe, Takahiko Murata, Chigumi Sato, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|May 15, 2018
Evaluation of Intraplaque Neovascularization Using Superb Microvascular Imaging and Contrast-Enhanced UltrasonographyKazumasa Oura, Tadayoshi Kato, Hideki Ohba, et al.
Pageof 10